Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Long-term Depression01:05

Long-term Depression

33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.6K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.5K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.5K
Depressants01:28

Depressants

474
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
474

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

7. Cervical facet pain: Degenerative alterations and whiplash-associated disorder.

Pain practice : the official journal of World Institute of Pain·2025
Same author

Endobronchial Ultrasonography to Assess and Evaluate Tracheobronchial Tree Invasion in cT4b Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy: Assessment of Resectability.

Annals of surgical oncology·2024
Same author

Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual-echo arterial spin labeling MRI study.

Headache·2024
Same author

Opioid-induced respiratory depression.

BJA education·2024
Same author

[Pain in cancer].

Nederlands tijdschrift voor geneeskunde·2023
Same author

Patient-embodied virtual reality as a learning tool for therapeutic communication skills among anaesthesiologists: A phenomenological study.

Patient education and counseling·2023

Related Experiment Video

Updated: Feb 11, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.4K

Esketamine counters opioid-induced respiratory depression.

K Jonkman1, E van Rijnsoever1, E Olofsen1

  • 1Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.

British Journal of Anaesthesia
|April 18, 2018
PubMed
Summary

Esketamine effectively reversed opioid-induced respiratory depression by stimulating breathing. This effect was linked to increased ventilatory carbon dioxide sensitivity, offering a potential therapeutic strategy.

Keywords:
esketamineopioidrespiratory compromiserespiratory depressionreversal

More Related Videos

Burn Injury-Induced Pain and Depression-Like Behavior in Mice
07:08

Burn Injury-Induced Pain and Depression-Like Behavior in Mice

Published on: September 29, 2021

3.7K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

23.6K

Related Experiment Videos

Last Updated: Feb 11, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.4K
Burn Injury-Induced Pain and Depression-Like Behavior in Mice
07:08

Burn Injury-Induced Pain and Depression-Like Behavior in Mice

Published on: September 29, 2021

3.7K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

23.6K

Area of Science:

  • Anesthesiology and Pharmacology
  • Respiratory Physiology

Background:

  • Opioids are known to cause dangerous respiratory depression.
  • Understanding countermeasures for opioid-induced respiratory depression is critical.

Purpose of the Study:

  • To investigate if esketamine can stimulate breathing in a human model of opioid-induced respiratory depression.
  • To determine the mechanism by which esketamine affects respiratory control.

Main Methods:

  • A randomized, double-blind, placebo-controlled, crossover study involving 12 healthy volunteers.
  • Esketamine infusion was administered on top of remifentanil-induced respiratory depression.
  • Population pharmacokinetic-pharmacodynamic analysis was used to assess drug effects.

Main Results:

  • Remifentanil reduced ventilation by approximately 40% through effects on baseline ventilation and CO2 sensitivity.
  • Esketamine selectively increased breathing by enhancing ventilatory CO2 sensitivity.
  • Esketamine's effect was rapid, dose-dependent, and linked to plasma concentrations.

Conclusions:

  • Esketamine effectively counteracted remifentanil-induced respiratory depression.
  • The primary mechanism involved restoring ventilatory CO2 chemosensitivity.
  • Esketamine shows promise as a treatment for opioid-induced respiratory depression.